img

Global Meloxicam Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Meloxicam Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. 
Meloxicam Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Meloxicam Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Osteoarthritis in Adults (OA) and Rheumatoid Arthritis in Adults (RA) are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Meloxicam Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Segment by Type
Tablet
Capsule

Segment by Application


Osteoarthritis in Adults (OA)
Rheumatoid Arthritis in Adults (RA)
Pediatric Patients

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Meloxicam Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Meloxicam Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Meloxicam Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Meloxicam Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Meloxicam Drug introduction, etc. Meloxicam Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Meloxicam Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Meloxicam Drug Market Overview
1.1 Meloxicam Drug Product Overview
1.2 Meloxicam Drug Market Segment by Type
1.2.1 Tablet
1.2.2 Capsule
1.3 Global Meloxicam Drug Market Size by Type
1.3.1 Global Meloxicam Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Meloxicam Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Meloxicam Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Meloxicam Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Meloxicam Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Meloxicam Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Meloxicam Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Meloxicam Drug Sales Breakdown by Type (2018-2024)
2 Global Meloxicam Drug Market Competition by Company
2.1 Global Top Players by Meloxicam Drug Sales (2018-2024)
2.2 Global Top Players by Meloxicam Drug Revenue (2018-2024)
2.3 Global Top Players by Meloxicam Drug Price (2018-2024)
2.4 Global Top Manufacturers Meloxicam Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Meloxicam Drug Market Competitive Situation and Trends
2.5.1 Meloxicam Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Meloxicam Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meloxicam Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Meloxicam Drug Market
2.8 Key Manufacturers Meloxicam Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Meloxicam Drug Status and Outlook by Region
3.1 Global Meloxicam Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Meloxicam Drug Historic Market Size by Region
3.2.1 Global Meloxicam Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Meloxicam Drug Sales in Value by Region (2018-2024)
3.2.3 Global Meloxicam Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Meloxicam Drug Forecasted Market Size by Region
3.3.1 Global Meloxicam Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Meloxicam Drug Sales in Value by Region (2024-2029)
3.3.3 Global Meloxicam Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Meloxicam Drug by Application
4.1 Meloxicam Drug Market Segment by Application
4.1.1 Osteoarthritis in Adults (OA)
4.1.2 Rheumatoid Arthritis in Adults (RA)
4.1.3 Pediatric Patients
4.2 Global Meloxicam Drug Market Size by Application
4.2.1 Global Meloxicam Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Meloxicam Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Meloxicam Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Meloxicam Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Meloxicam Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Meloxicam Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Meloxicam Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Meloxicam Drug Sales Breakdown by Application (2018-2024)
5 North America Meloxicam Drug by Country
5.1 North America Meloxicam Drug Historic Market Size by Country
5.1.1 North America Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Meloxicam Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Meloxicam Drug Sales in Value by Country (2018-2024)
5.2 North America Meloxicam Drug Forecasted Market Size by Country
5.2.1 North America Meloxicam Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Meloxicam Drug Sales in Value by Country (2024-2029)
6 Europe Meloxicam Drug by Country
6.1 Europe Meloxicam Drug Historic Market Size by Country
6.1.1 Europe Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Meloxicam Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Meloxicam Drug Sales in Value by Country (2018-2024)
6.2 Europe Meloxicam Drug Forecasted Market Size by Country
6.2.1 Europe Meloxicam Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Meloxicam Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Meloxicam Drug by Region
7.1 Asia-Pacific Meloxicam Drug Historic Market Size by Region
7.1.1 Asia-Pacific Meloxicam Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Meloxicam Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Meloxicam Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Meloxicam Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Meloxicam Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Meloxicam Drug Sales in Value by Region (2024-2029)
8 Latin America Meloxicam Drug by Country
8.1 Latin America Meloxicam Drug Historic Market Size by Country
8.1.1 Latin America Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Meloxicam Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Meloxicam Drug Sales in Value by Country (2018-2024)
8.2 Latin America Meloxicam Drug Forecasted Market Size by Country
8.2.1 Latin America Meloxicam Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Meloxicam Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Meloxicam Drug by Country
9.1 Middle East and Africa Meloxicam Drug Historic Market Size by Country
9.1.1 Middle East and Africa Meloxicam Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Meloxicam Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Meloxicam Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Meloxicam Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Meloxicam Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Meloxicam Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boehringer-Ingelheim
10.1.1 Boehringer-Ingelheim Company Information
10.1.2 Boehringer-Ingelheim Introduction and Business Overview
10.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Boehringer-Ingelheim Meloxicam Drug Products Offered
10.1.5 Boehringer-Ingelheim Recent Development
10.2 TerSera Therapeutics
10.2.1 TerSera Therapeutics Company Information
10.2.2 TerSera Therapeutics Introduction and Business Overview
10.2.3 TerSera Therapeutics Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 TerSera Therapeutics Meloxicam Drug Products Offered
10.2.5 TerSera Therapeutics Recent Development
10.3 Iroko Pharmaceuticals
10.3.1 Iroko Pharmaceuticals Company Information
10.3.2 Iroko Pharmaceuticals Introduction and Business Overview
10.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Iroko Pharmaceuticals Meloxicam Drug Products Offered
10.3.5 Iroko Pharmaceuticals Recent Development
10.4 Apotex
10.4.1 Apotex Company Information
10.4.2 Apotex Introduction and Business Overview
10.4.3 Apotex Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Apotex Meloxicam Drug Products Offered
10.4.5 Apotex Recent Development
10.5 Yung Shin Pharmaceutical
10.5.1 Yung Shin Pharmaceutical Company Information
10.5.2 Yung Shin Pharmaceutical Introduction and Business Overview
10.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Yung Shin Pharmaceutical Meloxicam Drug Products Offered
10.5.5 Yung Shin Pharmaceutical Recent Development
10.6 Breckenridge Pharmaceutical
10.6.1 Breckenridge Pharmaceutical Company Information
10.6.2 Breckenridge Pharmaceutical Introduction and Business Overview
10.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Breckenridge Pharmaceutical Meloxicam Drug Products Offered
10.6.5 Breckenridge Pharmaceutical Recent Development
10.7 Zydus Pharmaceuticals
10.7.1 Zydus Pharmaceuticals Company Information
10.7.2 Zydus Pharmaceuticals Introduction and Business Overview
10.7.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Zydus Pharmaceuticals Meloxicam Drug Products Offered
10.7.5 Zydus Pharmaceuticals Recent Development
10.8 Unichem Pharmaceuticals
10.8.1 Unichem Pharmaceuticals Company Information
10.8.2 Unichem Pharmaceuticals Introduction and Business Overview
10.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Unichem Pharmaceuticals Meloxicam Drug Products Offered
10.8.5 Unichem Pharmaceuticals Recent Development
10.9 Strides Pharma
10.9.1 Strides Pharma Company Information
10.9.2 Strides Pharma Introduction and Business Overview
10.9.3 Strides Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Strides Pharma Meloxicam Drug Products Offered
10.9.5 Strides Pharma Recent Development
10.10 Cipla
10.10.1 Cipla Company Information
10.10.2 Cipla Introduction and Business Overview
10.10.3 Cipla Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Cipla Meloxicam Drug Products Offered
10.10.5 Cipla Recent Development
10.11 Dr. Reddy's Laboratories
10.11.1 Dr. Reddy's Laboratories Company Information
10.11.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.11.3 Dr. Reddy's Laboratories Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Dr. Reddy's Laboratories Meloxicam Drug Products Offered
10.11.5 Dr. Reddy's Laboratories Recent Development
10.12 Glenmark Pharmaceuticals
10.12.1 Glenmark Pharmaceuticals Company Information
10.12.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Glenmark Pharmaceuticals Meloxicam Drug Products Offered
10.12.5 Glenmark Pharmaceuticals Recent Development
10.13 Teva
10.13.1 Teva Company Information
10.13.2 Teva Introduction and Business Overview
10.13.3 Teva Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Teva Meloxicam Drug Products Offered
10.13.5 Teva Recent Development
10.14 PuraCap Pharmaceutical
10.14.1 PuraCap Pharmaceutical Company Information
10.14.2 PuraCap Pharmaceutical Introduction and Business Overview
10.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 PuraCap Pharmaceutical Meloxicam Drug Products Offered
10.14.5 PuraCap Pharmaceutical Recent Development
10.15 TARO
10.15.1 TARO Company Information
10.15.2 TARO Introduction and Business Overview
10.15.3 TARO Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 TARO Meloxicam Drug Products Offered
10.15.5 TARO Recent Development
10.16 Lupin Pharmaceuticals
10.16.1 Lupin Pharmaceuticals Company Information
10.16.2 Lupin Pharmaceuticals Introduction and Business Overview
10.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Lupin Pharmaceuticals Meloxicam Drug Products Offered
10.16.5 Lupin Pharmaceuticals Recent Development
10.17 Aurobindo Pharma
10.17.1 Aurobindo Pharma Company Information
10.17.2 Aurobindo Pharma Introduction and Business Overview
10.17.3 Aurobindo Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Aurobindo Pharma Meloxicam Drug Products Offered
10.17.5 Aurobindo Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Meloxicam Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Meloxicam Drug Industrial Chain Analysis
11.4 Meloxicam Drug Market Dynamics
11.4.1 Meloxicam Drug Industry Trends
11.4.2 Meloxicam Drug Market Drivers
11.4.3 Meloxicam Drug Market Challenges
11.4.4 Meloxicam Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Meloxicam Drug Distributors
12.3 Meloxicam Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablet
Table 2. Major Company of Capsule
Table 3. Global Meloxicam Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Meloxicam Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Meloxicam Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Meloxicam Drug Market Share in Value by Type (2018-2024)
Table 8. Global Meloxicam Drug Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Meloxicam Drug Sales by Type (2024-2029) & (K Units)
Table 10. Global Meloxicam Drug Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Meloxicam Drug Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Meloxicam Drug Sales Market Share in Value by Type (2024-2029)
Table 13. Global Meloxicam Drug Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Meloxicam Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Meloxicam Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Meloxicam Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Meloxicam Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Meloxicam Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Meloxicam Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Meloxicam Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Meloxicam Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Meloxicam Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Meloxicam Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Meloxicam Drug Sales Share by Company (2018-2024)
Table 26. Global Meloxicam Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Meloxicam Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Meloxicam Drug Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Meloxicam Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Meloxicam Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meloxicam Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Meloxicam Drug Market
Table 33. Key Manufacturers Meloxicam Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Meloxicam Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Meloxicam Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Meloxicam Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Meloxicam Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Meloxicam Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Meloxicam Drug Sales by Region (2024-2029) & (K Units)
Table 42. Global Meloxicam Drug Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Meloxicam Drug Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Meloxicam Drug Sales Market Share in Value by Region (2024-2029)
Table 45. Global Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Meloxicam Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Meloxicam Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Meloxicam Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Meloxicam Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Meloxicam Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Meloxicam Drug Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Meloxicam Drug Sales by Application (2024-2029) & (K Units)
Table 53. Global Meloxicam Drug Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Meloxicam Drug Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Meloxicam Drug Sales Market Share in Value by Application (2024-2029)
Table 56. Global Meloxicam Drug Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Meloxicam Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Meloxicam Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Meloxicam Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Meloxicam Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Meloxicam Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Meloxicam Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Meloxicam Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Meloxicam Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Meloxicam Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Meloxicam Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Meloxicam Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Meloxicam Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Meloxicam Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 72. North America Meloxicam Drug Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Meloxicam Drug Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Meloxicam Drug Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Meloxicam Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Meloxicam Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Meloxicam Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 80. Europe Meloxicam Drug Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Meloxicam Drug Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Meloxicam Drug Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Meloxicam Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Meloxicam Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Meloxicam Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Meloxicam Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Meloxicam Drug Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Meloxicam Drug Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Meloxicam Drug Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Meloxicam Drug Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Meloxicam Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Meloxicam Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Meloxicam Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Meloxicam Drug Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Meloxicam Drug Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Meloxicam Drug Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Meloxicam Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Meloxicam Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Meloxicam Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Meloxicam Drug Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Meloxicam Drug Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Meloxicam Drug Sales Market Share in Value by Country (2024-2029)
Table 107. Boehringer-Ingelheim Company Information
Table 108. Boehringer-Ingelheim Introduction and Business Overview
Table 109. Boehringer-Ingelheim Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Boehringer-Ingelheim Meloxicam Drug Product
Table 111. Boehringer-Ingelheim Recent Development
Table 112. TerSera Therapeutics Company Information
Table 113. TerSera Therapeutics Introduction and Business Overview
Table 114. TerSera Therapeutics Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. TerSera Therapeutics Meloxicam Drug Product
Table 116. TerSera Therapeutics Recent Development
Table 117. Iroko Pharmaceuticals Company Information
Table 118. Iroko Pharmaceuticals Introduction and Business Overview
Table 119. Iroko Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Iroko Pharmaceuticals Meloxicam Drug Product
Table 121. Iroko Pharmaceuticals Recent Development
Table 122. Apotex Company Information
Table 123. Apotex Introduction and Business Overview
Table 124. Apotex Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Apotex Meloxicam Drug Product
Table 126. Apotex Recent Development
Table 127. Yung Shin Pharmaceutical Company Information
Table 128. Yung Shin Pharmaceutical Introduction and Business Overview
Table 129. Yung Shin Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Yung Shin Pharmaceutical Meloxicam Drug Product
Table 131. Yung Shin Pharmaceutical Recent Development
Table 132. Breckenridge Pharmaceutical Company Information
Table 133. Breckenridge Pharmaceutical Introduction and Business Overview
Table 134. Breckenridge Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Breckenridge Pharmaceutical Meloxicam Drug Product
Table 136. Breckenridge Pharmaceutical Recent Development
Table 137. Zydus Pharmaceuticals Company Information
Table 138. Zydus Pharmaceuticals Introduction and Business Overview
Table 139. Zydus Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Zydus Pharmaceuticals Meloxicam Drug Product
Table 141. Zydus Pharmaceuticals Recent Development
Table 142. Unichem Pharmaceuticals Company Information
Table 143. Unichem Pharmaceuticals Introduction and Business Overview
Table 144. Unichem Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Unichem Pharmaceuticals Meloxicam Drug Product
Table 146. Unichem Pharmaceuticals Recent Development
Table 147. Strides Pharma Company Information
Table 148. Strides Pharma Introduction and Business Overview
Table 149. Strides Pharma Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Strides Pharma Meloxicam Drug Product
Table 151. Strides Pharma Recent Development
Table 152. Cipla Company Information
Table 153. Cipla Introduction and Business Overview
Table 154. Cipla Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Cipla Meloxicam Drug Product
Table 156. Cipla Recent Development
Table 157. Dr. Reddy's Laboratories Company Information
Table 158. Dr. Reddy's Laboratories Introduction and Business Overview
Table 159. Dr. Reddy's Laboratories Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Dr. Reddy's Laboratories Meloxicam Drug Product
Table 161. Dr. Reddy's Laboratories Recent Development
Table 162. Glenmark Pharmaceuticals Company Information
Table 163. Glenmark Pharmaceuticals Introduction and Business Overview
Table 164. Glenmark Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Glenmark Pharmaceuticals Meloxicam Drug Product
Table 166. Glenmark Pharmaceuticals Recent Development
Table 167. Teva Company Information
Table 168. Teva Introduction and Business Overview
Table 169. Teva Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Teva Meloxicam Drug Product
Table 171. Teva Recent Development
Table 172. PuraCap Pharmaceutical Company Information
Table 173. PuraCap Pharmaceutical Introduction and Business Overview
Table 174. PuraCap Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. PuraCap Pharmaceutical Meloxicam Drug Product
Table 176. PuraCap Pharmaceutical Recent Development
Table 177. TARO Company Information
Table 178. TARO Introduction and Business Overview
Table 179. TARO Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. TARO Meloxicam Drug Product
Table 181. TARO Recent Development
Table 182. Lupin Pharmaceuticals Company Information
Table 183. Lupin Pharmaceuticals Introduction and Business Overview
Table 184. Lupin Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. Lupin Pharmaceuticals Meloxicam Drug Product
Table 186. Lupin Pharmaceuticals Recent Development
Table 187. Aurobindo Pharma Company Information
Table 188. Aurobindo Pharma Introduction and Business Overview
Table 189. Aurobindo Pharma Meloxicam Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Aurobindo Pharma Meloxicam Drug Product
Table 191. Aurobindo Pharma Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Meloxicam Drug Market Trends
Table 195. Meloxicam Drug Market Drivers
Table 196. Meloxicam Drug Market Challenges
Table 197. Meloxicam Drug Market Restraints
Table 198. Meloxicam Drug Distributors List
Table 199. Meloxicam Drug Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Meloxicam Drug Product Picture
Figure 2. Global Meloxicam Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Meloxicam Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Meloxicam Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Tablet
Figure 6. Global Tablet Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Capsule
Figure 8. Global Capsule Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Meloxicam Drug Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Meloxicam Drug Sales Market Share by Type in 2022 & 2029
Figure 11. North America Meloxicam Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Meloxicam Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Meloxicam Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Meloxicam Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Meloxicam Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Meloxicam Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Meloxicam Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Meloxicam Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Meloxicam Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Meloxicam Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Meloxicam Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Meloxicam Drug Revenue in 2022
Figure 23. Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Osteoarthritis in Adults (OA)
Figure 25. Global Osteoarthritis in Adults (OA) Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Rheumatoid Arthritis in Adults (RA)
Figure 27. Global Rheumatoid Arthritis in Adults (RA) Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Pediatric Patients
Figure 29. Global Pediatric Patients Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Meloxicam Drug Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Meloxicam Drug Sales Market Share by Application in 2022 & 2029
Figure 32. North America Meloxicam Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Meloxicam Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Meloxicam Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Meloxicam Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Meloxicam Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Meloxicam Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Meloxicam Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Meloxicam Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Meloxicam Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Meloxicam Drug Manufacturing Cost Structure
Figure 43. Meloxicam Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries